Crossmark

Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations

Crossref DOI link: https://doi.org/10.1007/s11095-018-2478-2

Published Online: 2018-09-05

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pandey, Shweta

Kumar, Vijay

Leekha, Ankita

Rai, Nishant

Ahmad, Farhan Jalees

Verma, Anita Kamra

Talegaonkar, Sushama
Funding

Funding for this research was provided by:

Indian Council of Medical Research (BMS/FW/Nano/2015-20580/March15/14/govt)
License Information

Text and Data Mining valid from 2018-09-05
More Information

Article History

Received: 26 May 2018

Accepted: 7 August 2018

First Online: 5 September 2018

Document is current

Any future updates will be listed below